Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.
De Pas, Tommaso M
Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2011 - e819-22 p. digital
Publication Type: Case Reports; Journal Article
1527-7755
10.1200/JCO.2011.36.2251 doi
Aged
Antineoplastic Agents--therapeutic use
Base Sequence
Carcinoma, Large Cell--drug therapy
Carcinoma, Neuroendocrine--drug therapy
Female
Gefitinib
Genes, erbB-1
Humans
Lung Neoplasms--drug therapy
Molecular Sequence Data
Mutation
Neoplasm Metastasis
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2011 - e819-22 p. digital
Publication Type: Case Reports; Journal Article
1527-7755
10.1200/JCO.2011.36.2251 doi
Aged
Antineoplastic Agents--therapeutic use
Base Sequence
Carcinoma, Large Cell--drug therapy
Carcinoma, Neuroendocrine--drug therapy
Female
Gefitinib
Genes, erbB-1
Humans
Lung Neoplasms--drug therapy
Molecular Sequence Data
Mutation
Neoplasm Metastasis
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use